Item 5. Other Information
Item 5. Other Information
None
Item 6. Exhibits
Exhibit
Number
Description of Exhibit
31.1**
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2**
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS**
Inline XBRL Instance Document
101.SCH **
Inline XBRL Taxonomy Extension Schema Document
101.CAL **
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF **
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB **
Inline XBRL Taxonomy Extension Label Linkbase Document
104 **
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
** Provided herewith
21
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OptimizeRx Corporation
Date: August 9, 2022
By:
/s/ William J. Febbo
William J. Febbo
Title:
Chief Executive Officer
(principal executive officer)
OptimizeRx Corporation
Date: August 9, 2022
By:
/s/ Edward Stelmakh
Edward Stelmakh
Title:
Chief Financial Officer and
Chief Operations Officer
(principal financial and accounting officer)
22
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.